Group leader position on “Systems Genomics Approaches for the Study of Neuronal pathologies” – Institut de Biologie Valrose, Nice, France

A Group leader position is open at the Institut de Biologie Valrose (iBV), Nice, France. We are seeking a candidate developing independent research on the molecular bases of neuronal pathologies, combining systems-level approaches with functional studies aimed at the mechanistic understanding of these pathologies.

The candidate will benefit from dedicated lab and office spaces, as well as from free access to the iBV state-of-the-art technology platforms, including microscopy infrastructure, cytometry, histology, bioinformatics, synthetic biology and animal facilities for various model organisms. He/she will be strongly supported by the iBV to obtain an institutional permanent position and apply for a competitive starting package.

The iBV is an internationally recognized institute, presently hosting 26 research groups, with about 30 different nationalities, using English as a working language (http://ibv.unice.fr/).

Research at the iBV is dedicated to deciphering the basic principles of biology involved in health and disease. To this aim, iBV researchers use a wide range of biological model systems (yeast, worm, sea urchin, fly, zebrafish, mouse and organoids) as well as human tissues and patient-derived material. In the context of this call, the iBV is looking for a researcher with a strong track record and a potential to establish collaborative networks with clinicians working locally. He/she will also contribute to University initiatives aimed at strengthening local expertise in complex data analysis.

Interested candidates should send their application to Stéphane Noselli (Stephane.NOSELLI@univ-cotedazur.fr) and Florence Besse (Florence.BESSE@univ-cotedazur.fr) before the 23rd of September. Applications should be submitted as a single pdf and contain a curriculum vitae with 2-3 reference contacs, a short description of achievements and a research program of maximum 5 pages.